tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Mesoblast’s Remestemcel-L Outperforms Ruxolitinib in SR-aGvHD Treatment
Company AnnouncementsMesoblast’s Remestemcel-L Outperforms Ruxolitinib in SR-aGvHD Treatment
5m ago
State Street Ceases Substantial Holding in Mesoblast
PremiumCompany Announcements
State Street Ceases Substantial Holding in Mesoblast
2d ago
Mesoblast to Participate in Piper Sandler Healthcare Conference
PremiumCompany Announcements
Mesoblast to Participate in Piper Sandler Healthcare Conference
8d ago
Mesoblast upgraded to Buy at Jefferies as Ryoncil roll out continues
PremiumThe Fly
Mesoblast upgraded to Buy at Jefferies as Ryoncil roll out continues
17d ago
MESO
Mesoblast upgraded to Buy from Hold at Jefferies
PremiumThe Fly
Mesoblast upgraded to Buy from Hold at Jefferies
17d ago
MESO
Mesoblast and BMT CTN Launch Pivotal Trial for Ryoncil® in Adult aGvHD
PremiumCompany AnnouncementsMesoblast and BMT CTN Launch Pivotal Trial for Ryoncil® in Adult aGvHD
21d ago
Mesoblast collaborating with BMT CTN on trial of Ryoncil in acute GvHD
Premium
The Fly
Mesoblast collaborating with BMT CTN on trial of Ryoncil in acute GvHD
21d ago
MESO
Mesoblast appoints James O’Brien as CFO
Premium
The Fly
Mesoblast appoints James O’Brien as CFO
25d ago
ABBV
MESO
Mesoblast Appoints New CFO Amidst Commercial Transition
PremiumCompany Announcements
Mesoblast Appoints New CFO Amidst Commercial Transition
25d ago
Mesoblast to Discuss Opioid Reduction Data with FDA
PremiumCompany Announcements
Mesoblast to Discuss Opioid Reduction Data with FDA
1M ago
Mesoblast Director Increases Shareholding Through Option Exercise
PremiumCompany Announcements
Mesoblast Director Increases Shareholding Through Option Exercise
1M ago
Mesoblast Limited’s 2025 Annual Report Highlights Corporate Governance Commitment
PremiumCompany Announcements
Mesoblast Limited’s 2025 Annual Report Highlights Corporate Governance Commitment
2M ago
Mesoblast Limited Announces 2025 Annual General Meeting
PremiumCompany AnnouncementsMesoblast Limited Announces 2025 Annual General Meeting
2M ago
Mesoblast Limited Releases 2025 Corporate Governance Statement
Premium
Company Announcements
Mesoblast Limited Releases 2025 Corporate Governance Statement
2M ago
Mesoblast Sees 69% Revenue Surge for Ryoncil® Amid Expanding Market Reach
Premium
Company Announcements
Mesoblast Sees 69% Revenue Surge for Ryoncil® Amid Expanding Market Reach
2M ago
JPMorgan Chase & Co. Ceases Substantial Holding in Mesoblast Limited
PremiumCompany Announcements
JPMorgan Chase & Co. Ceases Substantial Holding in Mesoblast Limited
2M ago
Mesoblast Limited Announces Cessation of Securities
PremiumCompany Announcements
Mesoblast Limited Announces Cessation of Securities
2M ago
Mesoblast Limited to Quote 3 Million New Securities on ASX
PremiumCompany Announcements
Mesoblast Limited to Quote 3 Million New Securities on ASX
2M ago
Mesoblast Reports 66% Revenue Surge for Ryoncil in Second Quarter
PremiumCompany Announcements
Mesoblast Reports 66% Revenue Surge for Ryoncil in Second Quarter
2M ago
Mesoblast reports Q2 Ryoncil revenue up 66% y/y
PremiumThe FlyMesoblast reports Q2 Ryoncil revenue up 66% y/y
2M ago
MESO
Mesoblast receives J-Code for Ryoncil from Medicare & Medicaid Services
Premium
The Fly
Mesoblast receives J-Code for Ryoncil from Medicare & Medicaid Services
2M ago
MESO
Mesoblast’s Ryoncil® Gains Medicare & Medicaid J-Code for Enhanced Access
Premium
Company Announcements
Mesoblast’s Ryoncil® Gains Medicare & Medicaid J-Code for Enhanced Access
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >